Progress in the safety of chimeric antigen receptor T cells therapy
10.3760/cma.j.cn115356-20210114-00015
- VernacularTitle:嵌合抗原受体T细胞治疗安全性研究进展
- Author:
Huiwen JIANG
;
Heng MEI
- From:
Journal of Leukemia & Lymphoma
2021;30(2):65-67
- CountryChina
- Language:Chinese
-
Abstract:
Chimeric antigen receptor T cells (CAR-T) therapy is progressing rapidly, and its safety has been widely concerned. At the 62nd American Society of Hematology Annual Meeting, a series of reports on the mechanism, predictive indicators and treatment strategies of major adverse reactions were carried out. These reports have certain guiding significance for comprehensively improving the safety of CAR-T therapy.
